Log In
Print this Print this

Avandamet XR, rosiglitazone/metformin

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionExtended-release combination of rosiglitazone and metformin
Molecular Target Peroxisome proliferation activated receptor (PPAR) gamma
Mechanism of ActionPeroxisome proliferation activated receptor (PPAR) gamma agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type ll diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today